G220291-NCT05624918

Dynamic List Information
Dynamic List Data
Study Title
A Phase II Study of Peri-Operative NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
Sponsor Name
Ashish Manne
NCT Number
NCT05624918
IDE Number
G220291
CMS Approval Date
2024-04-16
Category
A